Evidence map›Paper›PMID 40686207›Full record

ArticleCirculation2025

Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.

Salomeh Keyhani, Beth E Cohen, Marzieh Vali, Katherine J Hoggatt, Dawn M Bravata, Peter C Austin, Emily Lum, Deborah Hasin, Carl Grunfeld, Michael G Shlipak

Abstract read
In one paragraph

Article in Circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Salomeh KeyhaniCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).ORCID 0000-0001-9124-9618
Beth E CohenCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).ORCID 0000-0002-6166-0761
Marzieh ValiNorthern California Institute for Research and Education, San Francisco (M.V., E.L.).
Katherine J HoggattCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).
Dawn M BravataCenter for Health Information and Communication, Richard L. Roudebush VA Medical Center, Indianapolis, IN (D.M.B.).ORCID 0000-0002-3048-2536
Peter C AustinUniversity of Toronto, Canada (P.C.A.).ORCID 0000-0003-3337-233X
Emily LumNorthern California Institute for Research and Education, San Francisco (M.V., E.L.).
Deborah HasinDepartment of Psychiatry, Vagelos School of Medicine, Columbia University, New York, NY (D.H.).ORCID 0000-0002-6533-7021
Carl GrunfeldCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).ORCID 0000-0003-3501-4421
Michael G ShlipakCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).ORCID 0000-0002-9559-204X

Funding

Impact of marijuana on adherence, risk factor control and cardiovascular eventsR01HL130484 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2017 to 2020
$2.9M
NHLBI NIH HHS R01 HL130484
6 · The paper itself

Abstract

backgroundWhether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to 68 years of age) with coronary artery disease.

methodsThe THC Cohort (Heart and Cannabis) comprised 4285 veterans (mean [SD] age, 67.5 [1.01] years; 2% female) with coronary artery disease who were born in 1950 to 1952. Participants were recruited between April 5, 2018, and March 12, 2020, interviewed about health behaviors, and then classified according to their self-reported cannabis smoking status in the previous 30 days. In a separate analysis, we classified participants according to any form of cannabis use (smoking, vaping, or edible use) versus nonuse in the past 30 days. Data on demographic, behavioral, and clinical characteristics were collected by telephone interview and from national Department of Veterans Affairs and Medicare data sources. The primary outcome included a composite of fatal and nonfatal stroke, fatal and nonfatal acute myocardial infarction, and cardiovascular death. The follow-up period for each patient extended from the date of their initial interview until the end of study (June 14, 2022). All participants were followed until they experienced an outcome or until the end of the follow-up period. Survey nonresponse weights and propensity score-based weights were used to reduce bias and confounding. Hazard ratios were estimated using cause-specific hazard models.

resultsThe cohort included 1015 veterans with coronary artery disease who reported smoking cannabis in the previous 30 days and 3122 veterans who did not smoke cannabis in the previous 30 days. Mean follow-up was 3.3 years, and 563 events occurred. Compared with veterans who did not smoke cannabis, smoking cannabis (past 30 days) was not associated with the composite outcome of acute myocardial infarction, stroke, and cardiovascular death (adjusted hazard ratio, 0.87 [95% CI, 0.61-1.24]). Similarly, use of any form of cannabis (smoking, vaping, dabbing, edibles) in the past 30 days was not associated with the composite outcome.

conclusionsIn this cohort of older veterans with coronary artery disease, self-reported cannabis use was not independently associated with increased cardiovascular events over a mean of 3.3 years of follow-up.

Indexed as

Coronary Artery DiseaseMarijuana SmokingVeteransAgedFemaleHumansMaleRisk FactorsUnited Statescannabiscoronary artery diseasemarijuana smokingmyocardial infarctionstroke

Identifiers

PMID40686207
PMCPMC12373293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.